Medicare Enrolled
Dr. Sandip Desai, MD
Optician · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Sandip Desai is an optician specialist in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 7,054 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Desai received a total of $14,758 from 50 pharmaceutical and/or device companies across 768 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in TX
$14,758 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,054
Medicare services
Top 10% in TX for optician
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,237 | $91 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,154 | $92 | $301 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
754 | $0 | $3 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
633 | $61 | $200 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
356 | $0 | $1 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
337 | $40 | $125 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
329 | $7 | $55 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
328 | $28 | $180 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
325 | $42 | $125 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
304 | $163 | $681 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
290 | $10 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
278 | $132 | $549 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
224 | $4 | $15 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
163 | $82 | $301 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $116 | $450 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
90 | $136 | $400 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
38 | $26 | $100 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
23 | $79 | $400 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
21 | $20 | $100 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
19 | $22 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $30 | $60 |
| New patient office visit, complex (60-74 min) | 17 | $151 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,758
Total received (2018-2024)
Avg $2,108/year across 7 years
Top 13% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
768
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,487
2023
$2,404
2022
$2,063
2021
$2,069
2020
$1,798
2019
$2,430
2018
$1,507
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$713
GlaxoSmithKline, LLC.
$404
GENZYME CORPORATION
$276
Regeneron Healthcare Solutions, Inc.
$270
Actelion Pharmaceuticals US, Inc.
$249
Amgen Inc.
$102
Abbott Laboratories
$92
Electromed, Inc.
$80
Insmed, Inc.
$68
Mylan Specialty L.P.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Merck Sharp & Dohme LLC
$40
Mallinckrodt Hospital Products Inc.
$28
Pulmonx Corporation
$24
SANOFI US SERVICES INC.
$18
ANI Pharmaceuticals, Inc.
$17
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,184
GlaxoSmithKline, LLC.
$2,397
Actelion Pharmaceuticals US, Inc.
$1,184
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,065
GENZYME CORPORATION
$1,012
Regeneron Healthcare Solutions, Inc.
$939
Electromed, Inc.
$688
Mylan Specialty L.P.
$575
Abbott Laboratories
$372
Genentech USA, Inc.
$294
United Therapeutics Corporation
$244
Sunovion Pharmaceuticals Inc.
$242
Amgen Inc.
$229
Mallinckrodt Hospital Products Inc.
$205
AbbVie Inc.
$178
Janssen Pharmaceuticals, Inc
$157
Teva Pharmaceuticals USA, Inc.
$151
Allergan Inc.
$147
Insmed, Inc.
$134
Edwards Lifesciences Corporation
$118
Novo Nordisk Inc
$103
BOSTON SCIENTIFIC CORPORATION
$103
Boston Scientific Corporation
$95
Philips Electronics North America Corporation
$91
Circassia Pharmaceuticals Inc
$66
Astellas Pharma US Inc
$63
Grifols USA, LLC
$62
Allergan, Inc.
$62
Shionogi Inc
$61
Merck Sharp & Dohme LLC
$55
Vanda Pharmaceuticals Inc.
$52
Mallinckrodt LLC
$50
Medtronic Vascular, Inc.
$48
PFIZER INC.
$30
Inogen, Inc.
$29
Gilead Sciences, Inc.
$25
Pulmonx Corporation
$24
MAYNE PHARMA INC.
$24
SANOFI-AVENTIS U.S. LLC
$24
Paratek Pharmaceuticals, Inc.
$23
Horizon Pharma plc
$23
ORGANOGENESIS INC.
$19
SANOFI US SERVICES INC.
$18
ANI Pharmaceuticals, Inc.
$17
Phadia US Inc.
$16
E.R. Squibb & Sons, L.L.C.
$14
Covis Pharma GmBH
$13
Harmony Biosciences LLC
$13
Exeltis, USA Inc.
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 45.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · AirDuo Digihaler · Arikayce · Austedo XR · BREO · BREZTRI · BROVANA · CARDIOMEMS · CHARTIS CATHETER · CRESEMBA · DUAKLIR PRESSAIR · DUPIXENT · ELIQUIS · EMBLEM · EV1000 Clinical Platform · Esbriet · FASENRA · Fetroja · HETLIOZ · Hetlioz · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · InogenOne · JARDIANCE · LATUDA · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · Puraply · RAYOS · RESONATE · Reveal LINQ · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Utibron · WINREVAIR · Wakix · Wegovy · XARELTO · Xembify · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
413
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desai is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Desai performed 1,237 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $14,758 from 50 companies across 768 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other opticians in Sugar Land?
Dr. Desai's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Sugar Land
Browse opticians in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology